Tunn UW - Search Results

1

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy.

Moyad MA, Newton RU, Tunn UW, Gruca D. Moyad MA, et al. Among authors: tunn uw. Res Rep Urol. 2016 Aug 16;8:133-43. doi: 10.2147/RRU.S107852. eCollection 2016. Res Rep Urol. 2016. PMID: 27574584 Free PMC article. Review.

2

High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients.

Tselis N, Tunn UW, Chatzikonstantinou G, Milickovic N, Baltas D, Ratka M, Zamboglou N. Tselis N, et al. Among authors: tunn uw. Radiat Oncol. 2013 May 8;8:115. doi: 10.1186/1748-717X-8-115. Radiat Oncol. 2013. PMID: 23656899 Free PMC article. Clinical Trial.

3

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation.

Tunn UW, Gruca D, Bacher P. Tunn UW, et al. Clin Interv Aging. 2013;8:457-64. doi: 10.2147/CIA.S27931. Epub 2013 Apr 26. Clin Interv Aging. 2013. PMID: 23637525 Free PMC article. Review.

4

High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results.

Zamboglou N, Tselis N, Baltas D, Buhleier T, Martin T, Milickovic N, Papaioannou S, Ackermann H, Tunn UW. Zamboglou N, et al. Among authors: tunn uw. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):672-8. doi: 10.1016/j.ijrobp.2012.07.004. Epub 2012 Aug 25. Int J Radiat Oncol Biol Phys. 2013. PMID: 22929859

5

Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy.

Tunn UW, Canepa G, Kochanowsky A, Kienle E. Tunn UW, et al. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):296-302. doi: 10.1038/pcan.2012.12. Prostate Cancer Prostatic Dis. 2012. PMID: 22733160 Clinical Trial.

6

Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.

Tunn UW, Stenzl A, Schultze-Seemann W, Strauss A, Kindler M, Miller K, Wirth MP, Zantl N, Schulze M, May C, Ruebel A, Birkholz K, Gruenwald V. Tunn UW, et al. Can J Urol. 2012 Jun;19(3):6261-7. Can J Urol. 2012. PMID: 22704310 Clinical Trial.

7

A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients.

Tunn UW. Tunn UW. BMC Urol. 2011 Jul 29;11:15. doi: 10.1186/1471-2490-11-15. BMC Urol. 2011. PMID: 21801354 Free PMC article. Clinical Trial.

8

Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe.

Tunn UW, Wiedey K. Tunn UW, et al. Prostate Cancer Prostatic Dis. 2009;12(1):83-7. doi: 10.1038/pcan.2008.52. Epub 2008 Nov 25. Prostate Cancer Prostatic Dis. 2009. PMID: 19030021 Clinical Trial.

9

Assessment and management of high-risk patients.

Tunn UW. Tunn UW. BJU Int. 2004 Dec;94 Suppl 3:11-3. doi: 10.1111/j.1464-410X.2004.05139.x. BJU Int. 2004. PMID: 15521887 Review. No abstract available.

10

Advanced prostate cancer treatment guidelines: European perspective.

Tunn UW. Tunn UW. BJU Int. 2004 Dec;94 Suppl 3:6. doi: 10.1111/j.1464-410X.2004.05136.x. BJU Int. 2004. PMID: 15521884 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters